The Numeris® Guided Coagulation Device with VisiTrax® integrates
The device is CE Mark approved for the coagulation of cardiac tissue using radiofrequency (RF) energy during cardiac surgery for the treatment of arrhythmias including Atrial Fibrillation (AFIB) or Atrial Flutter (AFL). The indication for use accurately describes the Company’s development effort to design the first epicardial ablation device for truly minimally invasive procedures. The device was designed to be flexible to allow the device to be positioned gently, under direct endoscopic visibility, throughout the atria. While nContact’s device was designed for the Convergent Procedure, most ablation designs were not originally designed for atrial fibrillation application but rather adopted for use as best technology available.